{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:51:59Z","timestamp":1761155519757},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.jdermsci.2011.08.007","type":"journal-article","created":{"date-parts":[[2011,8,29]],"date-time":"2011-08-29T14:50:13Z","timestamp":1314629413000},"page":"163-173","source":"Crossref","is-referenced-by-count":6,"title":["Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling"],"prefix":"10.1016","volume":"64","author":[{"given":"Yih-Lin","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Newman N.M.","family":"Pui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2011.08.007_bib0005","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc1913","article-title":"Comparing antibody and small-molecule therapies for cancer","volume":"6","author":"Imai","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1470-2045(05)70243-6","article-title":"Cutaneous side-effects of kinase inhibitors and blocking antibodies","volume":"6","author":"Robert","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0015","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1634\/theoncologist.2008-0149","article-title":"Do patients die from rashes from epidermal growth factor receptor inhibitors? A systematic review to help counsel patients about holding therapy","volume":"13","author":"Jatoi","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0020","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/annonc\/mdq387","article-title":"Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion","volume":"22","author":"Potthoff","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0025","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1158\/1078-0432.CCR-06-2610","article-title":"Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies","volume":"13","author":"Wacker","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0030","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc1970","article-title":"Mechanisms of cutaneous toxicities to EGFR inhibitors","volume":"6","author":"Lacouture","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jaad.2009.09.023","article-title":"Preliminary evidence for a role of mast cells in epidermal growth factor receptor inhibitor-induced pruritus","volume":"63","author":"Gerber","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0040","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12016-007-0029-4","article-title":"Mast cells and immunological skin diseases","volume":"33","author":"Navi","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0045","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/sj.jid.5701184","article-title":"The epidermal growth factor receptor system in skin repair and inflammation","volume":"128","author":"Pastore","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9440(10)63654-1","article-title":"Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation","volume":"163","author":"Mascia","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0055","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.4049\/jimmunol.174.8.5047","article-title":"ERK1\/2 regulates epidermal chemokine expression and skin inflammation","volume":"174","author":"Pastore","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0060","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1158\/0008-5472.CAN-09-0487","article-title":"Tumor necrosis factor-alpha and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in mice","volume":"69","author":"Surguladze","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1034\/j.1600-0536.2000.043005267.x","article-title":"Immediate contact hypersensitivity induced by repeated hapten challenge in mice","volume":"43","author":"Natsuaki","year":"2000","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jcb.20532","article-title":"Prospects: histone deacetylase inhibitors","volume":"96","author":"Dokmanovic","year":"2005","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0075","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/92.15.1210","article-title":"Histone deacetylase inhibitors: induction of differentiation or apoptosis of transformed cells","volume":"92","author":"Marks","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0080","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"27","author":"Lane","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1359-6446(04)03309-4","article-title":"Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?","volume":"10","author":"Blanchard","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0090","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/nrd3031","article-title":"Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells","volume":"8","author":"Wang","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0095","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.intimp.2008.08.017","article-title":"Effects of a selection of histone deacetylase inhibitors on mast cell activation and airway and colonic smooth muscle contraction","volume":"8","author":"Assem el-SK","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0100","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.4049\/jimmunol.169.4.2044","article-title":"Key role for mast cells in nonatopic asthma","volume":"169","author":"Kraneveld","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0105","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/1523-1747.ep12470344","article-title":"Mast cell participation during the elicitation of murine allergic contact hypersensitivity","volume":"88","author":"Kerdel","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0940-2993(00)80037-8","article-title":"Picryl chloride-induced allergic dermatitis in IQI\/Jic female mice","volume":"52","author":"Ikeda","year":"2000","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0115","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.4049\/jimmunol.130.6.2565","article-title":"Delayed hypersensitivity in mast-cell-deficient mice","volume":"130","author":"Thomas","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0120","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1126\/science.6494907","article-title":"Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice","volume":"226","author":"Galli","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0125","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/eji.1830270718","article-title":"Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation","volume":"27","author":"Kondo","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0130","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/1523-1747.ep12324061","article-title":"Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin","volume":"105","author":"Nakamura","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2011.08.007_bib0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jdermsci.2011.01.003","article-title":"Radiation-induced mast cell mediators differentially modulate chemokine release from dermal fibroblasts","volume":"61","author":"M\u00fcller","year":"2011","journal-title":"J Dermatol Sci"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181111002556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181111002556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T01:49:11Z","timestamp":1686275351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181111002556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0923181111002556"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2011.08.007","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}